T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Mondelez International
MDLZ
|
+$878M |
| 2 |
Apple
AAPL
|
+$693M |
| 3 |
Liberty Global Class C
LBTYK
|
+$683M |
| 4 |
Tesla
TSLA
|
+$666M |
| 5 |
NXP Semiconductors
NXPI
|
+$592M |
Top Sells
| 1 |
LNKD
LinkedIn Corporation
LNKD
|
+$1.07B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.03B |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$989M |
| 4 |
Pfizer
PFE
|
+$943M |
| 5 |
Gilead Sciences
GILD
|
+$862M |
Sector Composition
| 1 | Healthcare | 19.88% |
| 2 | Consumer Discretionary | 14.86% |
| 3 | Financials | 14.2% |
| 4 | Technology | 12.53% |
| 5 | Industrials | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SUPV
1426
Grupo Supervielle
SUPV
$484M
| $3.65M | ﹤0.01% |
+285,200
| New | +$3.65M |
|
1427
ResMed
RMD
$39.6B
| $3.6M | ﹤0.01% |
56,897
+3,932
| +7% | +$249K |
|
|
PBNC
1428
DELISTED
PARAGON COMMERCIAL CORPORATION
PBNC
| $3.55M | ﹤0.01% |
+101,400
| New | +$3.55M |
|
1429
SPS Commerce
SPSC
$4B
| $3.48M | ﹤0.01% |
114,880
-1,826,684
| -94% | -$55.4M |
|
|
HZN
1430
DELISTED
Horizon Global Corporation
HZN
| $3.48M | ﹤0.01% |
306,496
-484,050
| -61% | -$5.49M |
|
1431
XPO
XPO
$15.3B
| $3.45M | ﹤0.01% |
380,030
+26,181
| +7% | +$238K |
|
|
WR
1432
DELISTED
Westar Energy Inc
WR
| $3.42M | ﹤0.01% |
60,966
-2,077
| -3% | -$117K |
|
1433
ICICI Bank
IBN
$115B
| $3.41M | ﹤0.01% |
522,409
+116,580
| +29% | +$761K |
|
1434
Cedar Fair
FUN
$2.38B
| $3.39M | ﹤0.01% |
58,626
-100
| -0.2% | -$5.78K |
|
1435
Groupon
GRPN
$923M
| $3.37M | ﹤0.01% |
51,894
+40,710
| +364% | +$2.65M |
|
1436
Mid-America Apartment Communities
MAA
$16.6B
| $3.35M | ﹤0.01% |
31,443
+640
| +2% | +$68.1K |
|
1437
Teladoc Health
TDOC
$1.36B
| $3.34M | ﹤0.01% |
208,750
-310,245
| -60% | -$4.97M |
|
|
EV
1438
DELISTED
Eaton Vance Corp.
EV
| $3.34M | ﹤0.01% |
94,545
+3,835
| +4% | +$136K |
|
|
PRFT
1439
DELISTED
Perficient Inc
PRFT
| $3.33M | ﹤0.01% |
163,900
-2,900
| -2% | -$58.9K |
|
1440
John B. Sanfilippo & Son
JBSS
$737M
| $3.32M | ﹤0.01% |
+77,890
| New | +$3.32M |
|
1441
National Fuel Gas
NFG
$7.97B
| $3.31M | ﹤0.01% |
58,222
-859
| -1% | -$48.9K |
|
1442
Synopsys
SNPS
$79B
| $3.3M | ﹤0.01% |
61,030
-2,262
| -4% | -$122K |
|
|
ICPT
1443
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $3.25M | ﹤0.01% |
22,785
-800
| -3% | -$114K |
|
1444
Merus
MRUS
$5.26B
| $3.2M | ﹤0.01% |
+400,000
| New | +$3.2M |
|
|
EMWP
1445
DELISTED
Eros Media World PLC
EMWP
| $3.15M | ﹤0.01% |
9,670
-575
| -6% | -$187K |
|
1446
Exact Sciences
EXAS
$10.2B
| $3.15M | ﹤0.01% |
256,700
+20,500
| +9% | +$251K |
|
|
CETV
1447
DELISTED
Central European Media Enterprises Ltd
CETV
| $3.08M | ﹤0.01% |
1,457,900
+129,000
| +10% | +$272K |
|
1448
Cheniere Energy
LNG
$51.9B
| $3.05M | ﹤0.01% |
81,166
+5,316
| +7% | +$200K |
|
1449
Annaly Capital Management
NLY
$14.1B
| $3.03M | ﹤0.01% |
68,456
+3,298
| +5% | +$146K |
|
1450
Team
TISI
$81.8M
| $3.03M | ﹤0.01% |
12,206
-3,550
| -23% | -$882K |
|